SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Grandy who wrote (489)3/16/1997 3:18:00 PM
From: James Silverman   of 6136
 
You may well be right John.
But the point that you really hit on the button is that they are driving out some of the weaker hands. Anyone who has taken the time to read this entire thread should know the AGPH story quite well by now. The best counter of ST trading manipulations is to hold on for the longer haul. The stock traded for $10 little over a year ago and is now at $80, pullbacks and skeptics should be expected. Unlike a prior poster who felt AGPH will not make a dime for at least the next 2 years, I solidly disagree. I expect them to be very profitable in their next fiscal year ended June '98. I expect Viracept to supplant Crix in due time and am hopeful for some pleasant surprises surrounding the rest of the AGPH pipeline. In what will be a very bumpy ride up and down, I expect the stock to do quite well irrespective of rumors, shorts and day traders. AGPH has delivered on virtually every target they have made, its time to ignore rumors and just patiently hold as they continue to deliver.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News